Latin Labs Profile
Key Indicators
- Authorised Capital ₹ 4.00 M
as on 17-12-2024
- Paid Up Capital ₹ 3.72 M
as on 17-12-2024
- Company Age 12 Year, 7 Months
- Last Filing with ROC 31 Mar 2024
- Revenue 14.15%
(FY 2020)
- Profit 12.17%
(FY 2020)
- Ebitda 9.85%
(FY 2020)
- Net Worth 12.23%
(FY 2020)
- Total Assets -0.48%
(FY 2020)
About Latin Labs
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 4.00 M and a paid-up capital of Rs 3.72 M, as per Ministry of Corporate Affairs (MCA) records.
Santhi Tamilarasu, Meena, Dhamodharan, and Fifteen other members serve as directors at the Company.
- CIN/LLPIN
U85100TN2012PTC085924
- Company No.
085924
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
16 May 2012
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Chennai
Industry
Company Details
- Location
Villupuram, Tamil Nadu, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Latin Labs?
Board Members(18)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Santhi Tamilarasu  | Director | 16-May-2012 | Current |
| Meena | Director | 30-Mar-2015 | Current |
| Dhamodharan | Director | 16-May-2012 | Current |
| Jayaraman Ganesh | Director | 30-Mar-2015 | Current |
| Govindarajan Madhiyazhagan | Director | 30-Mar-2015 | Current |
| Anandha Venkatraman | Director | 16-May-2012 | Current |
Financial Performance of Latin Labs.
Latin Labs Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 14.15% increase. The company also saw a substantial improvement in profitability, with a 12.17% increase in profit. The company's net worth Soared by an impressive increase of 12.23%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Latin Labs?
In 2020, Latin Labs had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Lia Life Sciences Private LimitedActive 16 years 22 daysSanthi Tamilarasu and Meena are mutual person
Sugam Ct Scan Centre Private LimitedActive 20 years 4 monthsSanthi Tamilarasu and Meena are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Latin Labs?
Unlock and access historical data on people associated with Latin Labs, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Latin Labs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Latin Labs's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
